How Can We Help?
Skip to content
Wire frame hand with test tube


SEKSIUI XenoTech expands access to Red Blood Cell Partitioning service for improved pharmacokinetics assessments

  • May 5, 2021

To help customers better investigate their compounds’ clearance in preclinical drug development, SEKISUI XenoTech has expanded in vitro service capabilities...

Introducing New CryostaX Individual Donor Human Hepatocytes

  • March 1, 2021

Using single donor hepatocytes just got a whole lot easier. We’ve just released new Single Donor CryostaX®. If you’ve used...

SEKISUI again awarded as one of the most sustainable companies in the world!

  • January 27, 2021

The Canadian organization “Corporate Knights” annually ranks the 100 most sustainable companies in the world in its “Global 100” index....

ADME & DDI Contract Research Organization Announces New Website Launch

  • September 18, 2020

KANSAS CITY, Kansas– SEKISUI XenoTech, a specialty contract research organization (CRO) providing superior nonclinical studies and assay products to pharmaceutical...

SEKISUI XenoTech Receives New US Patent for a Method to Evaluate Xenobiotics as Immune-Modulators of Drug Transport and Metabolism in Hepatocytes

  • May 12, 2020

Kansas City, KS– SEKISUI XenoTech has been awarded US patent # 10,648,968 “In vitro test system to evaluate xenobiotics as...

SEKISUI XenoTech Expands Access to Top-Tier DDI Expertise & Consultancy

  • May 4, 2020

Kansas City, KS – SEKISUI XenoTech is expanding opportunities for clients to work with top-tier consultants to evaluate drug-drug interaction...

New Head of KC-Based Drug Development CRO Poised for Further Growth and Expansion

  • January 28, 2020

SEKISUI XenoTech announces the promotion of Dr. Darren Warren to President and Chief Executive Officer...

SEKISUI XenoTech Announces Expanded Consulting Opportunities Available to Clients

  • September 5, 2019

Kansas City, KS- SEKISUI XenoTech now provides the opportunity for clients to work with top-tier consultants to analyze critical components...

SEKISUI XenoTech Announces Enhanced Synergy in ADME Testing Services

  • July 2, 2019

Kansas City, KS– SEKISUI XenoTech is collaborating with the Drug Development Solutions Center to offer a full suite of nonclinical testing services specializing in...

SEKISUI XenoTech Celebrates 25th Anniversary

  • July 1, 2019

In 2019, SEKISUI XenoTech celebrated its 25th birthday, and our Japan branch turned 64! Read about our journey from a...